Home / Sweden / Oncopeptides AB
Oncopeptides AB Short position disclosed on September 22, 2026.
Follow
1.19% of the capital sold short
1 disclosing fund
439 disclosures on record
SE0009414576 ISIN code
Evolution of the disclosed total 0% 0.5% 1% 1.5% 2%
Oct 2025 Jan 2026 Apr 2026 Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up. Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart. July 23, 2018 today
Open positions The funds disclosing a short position that is still open. Fund Twelve months % of capital Over the year Since GSA Capital Partners LLP 1.19% new September 22, 2026
On the other side: the funds that hold Oncopeptides AB Titelia
Follow by RSS
Get the moves on Oncopeptides AB by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures 439 disclosures on record for this share. Date Fund % of capital End of publication October 14, 2021 Citadel Advisors LLC 0.60% October 13, 2021 Worldquant LLC 1.05% October 13, 2021 Citadel Advisors LLC 0.57% October 12, 2021 Worldquant LLC 0.92% October 12, 2021 Citadel Advisors LLC 0.00% October 11, 2021 Qube Research & Technologies Limited 0.89% October 11, 2021 Worldquant LLC 0.80% October 11, 2021 Mangrove Partners 0.73% October 11, 2021 Citadel Advisors LLC 0.51% October 8, 2021 Mangrove Partners 0.93% October 8, 2021 Worldquant LLC 0.67% October 8, 2021 Citadel Advisors LLC 0.00% October 7, 2021 Qube Research & Technologies Limited 1.02% October 7, 2021 Citadel Advisors LLC 0.70% October 7, 2021 Marshall Wace LLP 0.00% October 1, 2021 Arrowstreet Capital Limited Partnership 1.21% September 30, 2021 Citadel Advisors LLC 0.00% September 29, 2021 PDT Partners LLC 0.90% September 28, 2021 Marshall Wace LLP 0.79% September 20, 2021 Qube Research & Technologies Limited 0.67% September 17, 2021 Mangrove Partners 1.10% September 17, 2021 Qube Research & Technologies Limited 0.70% September 17, 2021 Citadel Advisors LLC 0.59% September 16, 2021 Qube Research & Technologies Limited 0.80% September 16, 2021 Citadel Advisors LLC 0.67% September 15, 2021 Qube Research & Technologies Limited 0.77% September 14, 2021 Citadel Advisors LLC 0.74% September 13, 2021 Mangrove Partners 1.00% September 13, 2021 Qube Research & Technologies Limited 0.64% September 10, 2021 Citadel Advisors LLC 0.82% September 8, 2021 Arrowstreet Capital Limited Partnership 1.19% September 8, 2021 Mangrove Partners 0.96% September 7, 2021 Citadel Advisors LLC 0.76% September 7, 2021 Consonance Capital Management LP 0.00% September 2, 2021 Marshall Wace LLP 0.86% September 2, 2021 Citadel Advisors LLC 0.81% September 2, 2021 Qube Research & Technologies Limited 0.53% August 31, 2021 Qube Research & Technologies Limited 0.00% August 30, 2021 Qube Research & Technologies Limited 0.54% August 27, 2021 Qube Research & Technologies Limited 0.00% August 26, 2021 Qube Research & Technologies Limited 0.55% August 24, 2021 Citadel Advisors LLC 1.06% August 24, 2021 Qube Research & Technologies Limited 0.73% August 23, 2021 Citadel Advisors LLC 1.12% August 20, 2021 Citadel Advisors LLC 1.35% August 20, 2021 Capital Fund Management SA 0.70% August 20, 2021 Qube Research & Technologies Limited 0.61% August 20, 2021 Consonance Capital Management LP 0.50% August 20, 2021 Worldquant LLC 0.00% August 19, 2021 Citadel Advisors LLC 1.22%
Download 439 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 6 of 9
Other companies sold short in Sweden Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Oncopeptides AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/oncopeptides-ab?page=6